Natco Pharma to incorporate subsidiary company in Indonesia

20 Apr 2023 Evaluate

Natco Pharma has received an approval from the Board of Directors to incorporate a Subsidiary Company in Indonesia with an investment up to an amount not exceeding $3 million, of which, initially the company will invest $1 million for a stake of 51% as capital contribution and balance will be invested by the company as and when the funds are required by the subsidiary Company.

The balance stake of 49% will be held by PT. Mitra Medis Exim (MME), that belongs to Mitra Jaya Group which is a 40 year old multi-diversified group, as the co-promoter of the proposed subsidiary Company. MME is in the business of distribution for active pharmaceutical ingredients and excipients for the end users in Indonesia.

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.

Natco Pharma Share Price

833.85 -6.00 (-0.71%)
22-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1371.55
Zydus Lifesciences 884.85
Lupin 2165.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×